Explore more publications!
Business Update France
Got News to Share?

Business Update France: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Business Update France.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on February 2, 2026

Celiveo annonce la prochaine disponibilité de Celiveo 365 sur le Cloud souverain Bleu, gestion des impressions Cloud
Feb. 2, 2026

Celiveo annonce la prochaine disponibilité de Celiveo 365 sur le Cloud souverain Bleu, gestion des impressions Cloud

Indeterminate EIN Presswire
AirX lance en Europe son site de réservation d'hélicoptères «AIROS Skyview», accélérant ainsi son expansion mondiale
Feb. 2, 2026

AirX lance en Europe son site de réservation d'hélicoptères «AIROS Skyview», accélérant ainsi son expansion mondiale

Indeterminate EIN Presswire
Influence Society and Consulate General of France to Host SOCIETIES in New York. A Symposium for Hospitality Leaders
Feb. 2, 2026

Influence Society and Consulate General of France to Host SOCIETIES in New York. A Symposium for Hospitality Leaders

Indeterminate EIN Presswire
STMicroelectronics expands sensors capabilities with closing of acquisition of NXP’s MEMS business
Feb. 2, 2026

STMicroelectronics expands sensors capabilities with closing of acquisition of NXP’s MEMS business

Indeterminate GlobeNewswire
STMicroelectronics étend son positionnement dans les capteurs avec la finalisation de l’acquisition de l’activité MEMS de NXP
Feb. 2, 2026

STMicroelectronics étend son positionnement dans les capteurs avec la finalisation de l’acquisition de l’activité MEMS de NXP

Indeterminate GlobeNewswire
WILL Opens on Kickstarter Pre-Launch, Blending Cat Play and a Responsive Companion Presence for Owners
Feb. 2, 2026

WILL Opens on Kickstarter Pre-Launch, Blending Cat Play and a Responsive Companion Presence for Owners

Indeterminate EIN Presswire
Wellturn Launches the F610 Omni-Scenario Multi-Zone Electric Fence
Feb. 2, 2026

Wellturn Launches the F610 Omni-Scenario Multi-Zone Electric Fence

Indeterminate EIN Presswire
Virtune AB (Publ) („Virtune“) hat die monatliche Neugewichtung für Januar 2026 des Virtune Crypto Altcoin Index ETPs durchgeführt
Feb. 2, 2026

Virtune AB (Publ) („Virtune“) hat die monatliche Neugewichtung für Januar 2026 des Virtune Crypto Altcoin Index ETPs durchgeführt

Indeterminate GlobeNewswire
Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for January 2026 of its Virtune Crypto Altcoin Index ETP
Feb. 2, 2026

Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for January 2026 of its Virtune Crypto Altcoin Index ETP

Indeterminate GlobeNewswire
Virtune AB (Publ) ("Virtune") har genomfört den månatliga rebalanseringen för januari 2026 av Virtune Crypto Altcoin Index ETP
Feb. 2, 2026

Virtune AB (Publ) ("Virtune") har genomfört den månatliga rebalanseringen för januari 2026 av Virtune Crypto Altcoin Index ETP

Indeterminate GlobeNewswire
Atos positioned as a Leader in the IDC MarketScape™: Middle East Managed Detection and Response (MDR) 2025 Vendor Assessment
Feb. 2, 2026

Atos positioned as a Leader in the IDC MarketScape™: Middle East Managed Detection and Response (MDR) 2025 Vendor Assessment

Indeterminate GlobeNewswire
Communiqué de presse : Le venglustat de Sanofi a atteint tous les critères d'évaluation principaux dans une étude de phase 3 sur la maladie de Gaucher de type 3
Feb. 2, 2026

Communiqué de presse : Le venglustat de Sanofi a atteint tous les critères d'évaluation principaux dans une étude de phase 3 sur la maladie de Gaucher de type 3

Indeterminate GlobeNewswire
Press Release: Sanofi’s venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher disease
Feb. 2, 2026

Press Release: Sanofi’s venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher disease

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions